Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis.

Journal of gastroenterology

Volumn 40, Issue 4, 2005, Pages 426-431

  Fujimoto, Yoshinori ^a   Ito, Akira ^a   Ishikawa, Yuji ^a   Inoue, Mitsutaka ^a   Suzuki, Yasuaki ^a   Ohhira, Masumi ^a   Ohtake, Takaaki ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; EM18 ANTIGEN; PARASITE ANTIGEN;

ADULT; AGED; ANIMAL; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG ADMINISTRATION; ECHINOCOCCUS MULTILOCULARIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; LIVER HYDATID CYST; LIVER RESECTION; MALE; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PARASITOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIGENS, HELMINTH; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS MULTILOCULARIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 23844514456     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1559-7     Document Type: Article

References (0)